Harford Simon N.R. sold FOLD
April 27, 2026 · Form 4 insider transaction
Harford Simon N.R. sold 143,595 shares of Amicus Therapeutics, Inc. at $14.50 per share, a transaction worth $2.08M. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
143,595
Price
$14.50
Total value
$2.08M
InsiderHarford Simon N.R.
RoleOfficer
SecurityCommon Stock
Transaction codeD: Disposition to the issuer
Transaction dateApril 27, 2026
Filing dateApril 27, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities were disposed of in connection with consummation of the acquisition of the Issuer by BioMarin Pharmaceutical Inc. (the "Merger"), which included 108,478 shares of Common Stock and 35,117 restricted stock units (which vested in full in connection with consummation of the Merger).